Table 2 Tail length (px), %DNA in tail and tail moment in the liver tissue of the negative control group and groups administered Ca(OH)2NPs, CaTiO3NPs and Y2O3NPs.
Group | Treatment | Tail length (px) | %DNA in tail | Tail moment |
|---|---|---|---|---|
I | Negative control | 6.13 ± 1.38a | 27.44 ± 8.41a | 2.08 ± 1.07a |
II | Ca(OH)2NPs | 14.93 ± 0.92b | 30.01 ± 3.35ab | 4.59 ± 0.63b |
III | CaTiO3NPs | 7.21 ± 0.06a | 37.94 ± 3.87b | 3.39 ± 0.30ab |
IV | Y2O3NPs | 6.05 ± 1.68a | 23.29 ± 4.44a | 1.73 ± 0.88a |
V | Combination | 6.42 ± 0.95a | 28.73 ± 2.99ab | 2.04 ± 0.44a |